Increased Risk for Heart Valve Disease Associated With Antiphospholipid Antibodies in Patients With Systemic Lupus ErythematosusClinical Perspective by S. Zuily, V. Regnault, C. Selton-Suty, V. Eschwège, J.-F. Bruntz, E. Bode-Dotto, E. De Maistre, P. Dotto, C. Perret-Guillaume, T. Lecompte, and D. Wahl Circulation Volume 124(2): July 12, 2011 Copyright © American Heart Association, Inc. All rights reserved.
Study flow diagram. S. Zuily et al. Circulation. 2011;124: Copyright © American Heart Association, Inc. All rights reserved.
Forest plot. S. Zuily et al. Circulation. 2011;124: Copyright © American Heart Association, Inc. All rights reserved.
Visual inspection of the L'Abbé plot revealed a good level of agreement without heterogeneity between studies included in the meta-analysis. S. Zuily et al. Circulation. 2011;124: Copyright © American Heart Association, Inc. All rights reserved.
S. Zuily et al. Circulation. 2011;124: Copyright © American Heart Association, Inc. All rights reserved.
S. Zuily et al. Circulation. 2011;124: Copyright © American Heart Association, Inc. All rights reserved.
Funnel plot of the risk of heart valve disease associated with antiphospholipid antibodies in patients with systemic lupus erythematosus. S. Zuily et al. Circulation. 2011;124: Copyright © American Heart Association, Inc. All rights reserved.